Best practices in the laboratory diagnosis, prognostication, prediction, and monitoring of Graves’ disease: role of TRAbs
BMC Endocrine Disorders · 2024
DOI: 10.1186/s12902-024-01809-9 ↗Kurz gefasst
Leitlinie in der Zeitschrift BMC Endocrine Disorders, 2024. Verfasst von Sanjay Kalra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Bharti Hospital, Kunjpura Road, Karnal, Haryana, 132001, India. brideknl@gmail.com. Hauptthemen laut MEDLINE: Autoantibodies, Graves Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Graves' disease (GD) is an autoimmune disorder characterized by activation of the TSH receptor by stimulatory autoantibodies (TSH Receptor Antibodies, or TRAbs), leading to unregulated thyroid hormone production. Diagnosis is largely based on the typical clinical picture and laboratory thyroid panel. Establishment of elevated serum levels of TRAbs by competitive binding assay or cell-binding assay has its unique role in diagnosis and management of GD, especially in the differential diagnosis, therapy selection, prognostication, evaluation of thyroid function during pregnancy, peri-conceptional and neonatal thyroid workup, and in certain special situation. Inclusion of TRAbs in GD diagnostic algorithm can improve cost-effectiveness of GD management. The current best practice guidelines were developed to provide evidence-based recommendations in the use of TRABs in GD management for healthcare providers in South Asia. A panel of endocrinologists with minimum 10 years of clinical experience in thyroid disorders reviewed existing literature and their quality, and after deliberation and discussion, developed 21 recommendations surrounding the best practices surrounding the role of TRAbs in GD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bharti Hospital, Kunjpura Road, Karnal, Haryana, 132001, India. brideknl@gmail.com.
- Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.
- Norvic International Hospital and Medical College, Thapathali, Kathmandu, Nepal.
- The National Hospital of Sri Lanka, Colombo, Sri Lanka.
- Shaukat Khanum Cancer Hospital & Research Center, Lahore, Pakistan.
- Diabetes, Endocrine & Metabolic Disease, Apollo Excelcare Hospitals, Boragaon, Assam, India.
Zitieren
APA
Kalra, S., Selim, S., Shrestha, D., Somasundaram, N., Raza, S. A., Baruah, M. P., Bhattacharya, S., Gadve, S., Bantwal, G., & Sahay, R. (2024). Best practices in the laboratory diagnosis, prognostication, prediction, and monitoring of Graves’ disease: role of TRAbs. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01809-9
Vancouver
Kalra S, Selim S, Shrestha D, Somasundaram N, Raza SA, Baruah MP, et al. Best practices in the laboratory diagnosis, prognostication, prediction, and monitoring of Graves’ disease: role of TRAbs. BMC Endocrine Disorders. 2024. doi:10.1186/s12902-024-01809-9
BibTeX
@article{Kalra2024,
author = {Kalra, Sanjay and Selim, Shahjada and Shrestha, Dina and Somasundaram, Noel and Raza, Syed Abbas and Baruah, Manash P and Bhattacharya, Saptarshi and Gadve, Sharvil and Bantwal, Ganapathi and Sahay, Rakesh},
title = {Best practices in the laboratory diagnosis, prognostication, prediction, and monitoring of Graves’ disease: role of TRAbs},
journal = {BMC Endocrine Disorders},
year = {2024},
doi = {10.1186/s12902-024-01809-9}
}
EUVIMED